SCHEMBL3787249

SCHEMBL3787249

NC(=O)c1cccc(C(N)=O)c1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.52
ALDH1A1 P00352 3/20 0.52
TSHR P16473 2/20 0.52
MAPT P10636 1/20 0.52
HPGD P15428 1/20 0.52
HSD17B10 Q99714 1/20 0.52
LMNA P02545 1/20 0.50
KMT2A Q03164 2/20 0.48
ATM Q13315 1/20 0.48
METAP2 P50579 1/20 0.48
GAA P10253 1/20 0.47
PARP1 P09874 5/20 0.46
BCAT2 O15382 1/20 0.46
KEAP1 Q14145 1/20 0.45
NFE2L2 Q16236 1/20 0.45
PDPK1 O15530 1/20 0.45
PLK4 O00444 1/20 0.42
CHEK1 O14757 1/20 0.42
AURKA O14965 1/20 0.42
DAPK3 O43293 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29787113 0.88 TSHR (0.65) KDM4EALDH1A1TSHRMAPTHPGD
SCHEMBL112377 0.88 TSHR (0.65) KDM4EALDH1A1TSHRMAPTHPGD
SCHEMBL23413049 0.86 KDM4E (0.61) KDM4EALDH1A1TSHRMAPTHPGD
SCHEMBL4878766 0.86 TSHR (0.63) KDM4EALDH1A1TSHRMAPTHPGD
SCHEMBL14661611 0.86 MMP2 (0.45) KDM4EALDH1A1TSHRMAPTHPGD
Hydrochloric Acid SCHEMBL4097230 0.86 TSHR (0.63) KDM4EALDH1A1TSHRMAPTHPGD
SCHEMBL1787597 0.84 METAP2 (0.45) KDM4EALDH1A1TSHRMAPTHPGD
SCHEMBL4910880 0.84 PBRM1 (0.53) KDM4EALDH1A1TSHRMAPTHPGD
SCHEMBL31141922 0.84 METAP2 (0.45) KDM4EALDH1A1TSHRMAPTHPGD
SCHEMBL2466290 0.84 CLCN2 (0.51) KDM4EALDH1A1TSHRMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 KDM4E 2606/4885ALDH1A1 4339/4885TSHR 1688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.